For research use only. Not for therapeutic Use.
FR 236924(Cat No.:I010698)is a potent and selective inhibitor of the enzyme dipeptidyl peptidase IV (DPP-IV), which plays a crucial role in regulating blood sugar levels by breaking down incretin hormones like GLP-1. By inhibiting DPP-IV, FR 236924 increases the levels of these hormones, enhancing insulin secretion and improving glucose control, making it a potential therapeutic candidate for type 2 diabetes. In addition to its antidiabetic properties, FR 236924 is also studied for its effects on immune modulation and inflammation. It has shown promise in preclinical studies for managing metabolic disorders and related conditions.
Catalog Number | I010698 |
CAS Number | 28399-31-7 |
Synonyms | Alternative Name: DCP-LA |
Molecular Formula | C20H36O2 |
Purity | ≥95% |
Target | TGF-beta/Smad |
Solubility | Soluble to 100 mM in DMSO and to 100 mM in ethanol |
Storage | Store at -20C |
IUPAC Name | 8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octanoic acid |
InChI | InChI=1S/C20H36O2/c1-2-3-7-10-16-13-18(16)15-19-14-17(19)11-8-5-4-6-9-12-20(21)22/h16-19H,2-15H2,1H3,(H,21,22) |
InChIKey | CONYTTFKIUJZOF-UHFFFAOYSA-N |
SMILES | CCCCCC1CC1CC2CC2CCCCCCCC(=O)O |